Literature DB >> 16783457

Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.

Wei Jen Lin1, Wen Tsung Lo, Chih Chun Chu, Mong Ling Chu, Chih Chien Wang.   

Abstract

BACKGROUND AND
PURPOSE: Intra-abdominal infection can be a life-threatening condition in children, and aggressive treatment is usually needed. The treatment should include surgical correction and drainage, and administration of antimicrobials that are effective against both aerobic and anaerobic microorganisms. This study investigated the microbiological characteristics of intra-abdominal infection of children in Taiwan.
METHODS: Data for bacterial specimens from 113 children (64 males), aged from 9 months to 18 years, who had community-acquired intra-abdominal infections at our hospital during a 10-year period were analyzed.
RESULTS: In total, 113 specimens were collected, including those with only aerobes (62%), and those with mixed aerobic and anaerobic species (35%). A total of 239 aerobes and 86 anaerobes were isolated. Polymicrobial infection was found in 79% of specimens. The predominant aerobe was Escherichia coli (42%), and Bacteroides fragilis (36%) was the most frequently isolated anaerobic microorganism. Enterococcus was detected in about 14% of Gram-positive aerobic isolates. Review of the results of antibiotic susceptibility testing revealed that the Gram-positive aerobes, apart from staphylococci, had a high susceptibility rate to ampicillin, and 84% of Gram-negative aerobes were susceptible to gentamicin. In addition, B. fragilis showed a high resistance rate to clindamycin (52%) but all of these isolates were susceptible to metronidazole.
CONCLUSION: Triple antibiotic combination therapy including ampicillin, gentamicin and metronidazole remains an alternative empirical antibiotic therapy for pediatric patients with mild to moderate community-acquired intra-abdominal infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783457

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  A focus on intra-abdominal infections.

Authors:  Massimo Sartelli
Journal:  World J Emerg Surg       Date:  2010-03-19       Impact factor: 5.469

2.  Evidence-based adjustment of antibiotic in pediatric complicated appendicitis in the era of antibiotic resistance.

Authors:  Kin Wai Edwin Chan; Kim Hung Lee; Jennifer Wai Cheung Mou; Sing Tak Cheung; Jennifer Dart Yin Sihoe; Yuk Him Tam
Journal:  Pediatr Surg Int       Date:  2010-02       Impact factor: 1.827

3.  2013 WSES guidelines for management of intra-abdominal infections.

Authors:  Massimo Sartelli; Pierluigi Viale; Fausto Catena; Luca Ansaloni; Ernest Moore; Mark Malangoni; Frederick A Moore; George Velmahos; Raul Coimbra; Rao Ivatury; Andrew Peitzman; Kaoru Koike; Ari Leppaniemi; Walter Biffl; Clay Cothren Burlew; Zsolt J Balogh; Ken Boffard; Cino Bendinelli; Sanjay Gupta; Yoram Kluger; Ferdinando Agresta; Salomone Di Saverio; Imtiaz Wani; Alex Escalona; Carlos Ordonez; Gustavo P Fraga; Gerson Alves Pereira Junior; Miklosh Bala; Yunfeng Cui; Sanjay Marwah; Boris Sakakushev; Victor Kong; Noel Naidoo; Adamu Ahmed; Ashraf Abbas; Gianluca Guercioni; Nereo Vettoretto; Rafael Díaz-Nieto; Ihor Gerych; Cristian Tranà; Mario Paulo Faro; Kuo-Ching Yuan; Kenneth Yuh Yen Kok; Alain Chichom Mefire; Jae Gil Lee; Suk-Kyung Hong; Wagih Ghnnam; Boonying Siribumrungwong; Norio Sato; Kiyoshi Murata; Takayuki Irahara; Federico Coccolini; Helmut A Segovia Lohse; Alfredo Verni; Tomohisa Shoko
Journal:  World J Emerg Surg       Date:  2013-01-08       Impact factor: 5.469

4.  The microbiology of bacterial peritonitis due to appendicitis in children.

Authors:  O Obinwa; M Casidy; J Flynn
Journal:  Ir J Med Sci       Date:  2013-12-18       Impact factor: 1.568

5.  The efficacy of combined therapy with metronidazole and broad-spectrum antibiotics on postoperative outcomes for pediatric patients with perforated appendicitis.

Authors:  Qingjuan Shang; Qiankun Geng; Xuebing Zhang; Chunbao Guo
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.